IP Library Granted Patent US 8,187,855
Granted Patent B2
US 8,187,855 · App. 12/735,868 · Granted May 29, 2012

Large-scale production of soluble hyaluronidase

Assignee: Halozyme, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,187,855
App. No.
12/735,868
Granted
May 29, 2012
Kind
B2
Abstract

Provided are methods for preparing large-scale preparations of soluble hyaluronidases. The methods employ cells that contain a plurality of active copies of nucleic acid encoding the soluble hyaluronidase and a plurality of feedings and temperature changes, whereby the encoded soluble hyaluronidase is secreted into the cell culture medium.

Claims (72)

1. A method for producing soluble rHuPH20, comprising:

a) inoculating cell medium in a bioreactor with an inoculum of cells that encode soluble rHuPH20 to produce a cell culture, wherein:

the cells comprise between 150 and 300 copies of nucleic acid encoding soluble rHuPH20;

the bioreactor contains at least 100 liters of cell culture;

about 10 10 -10 11 cells are inoculated per 100 liters cell culture; and

the cells are cultured at a set temperature;

b) feeding the cells with a first feed medium containing glucose, L -alanyl- L -glutamine, human insulin and yeast extract in amounts sufficient to increase cell growth and peak cell density, and to increase soluble rHuPH20 synthesis, wherein the feed medium is added to the culture at a volume of 0.5% or about 0.5% to 20% or about 20% of the cell culture volume;

c) feeding the cells with a second feed medium containing glucose, L -alanyl- L -glutamine, yeast extract and sodium butyrate in amounts sufficient to increase soluble rHuPH20 synthesis and induce cell cycle arrest; and

lowering the temperature compared to the temperature in step a) to a temperature sufficient to increase cell cycle arrest, increase cell viability and stabilize the soluble hyaluronidase; wherein:

the amount of L -alanyl- L -glutamine is decreased compared to the amount of L -alanyl- L -glutamine in step b);

the amount of yeast extract is increased compared to the amount of yeast extract in step b); and

the feed medium is added to the culture at a volume of 0.5% or about 0.5% to 20% of the cell culture volume;

d) feeding the cells with a third feed medium containing glucose, L -alanyl- L -glutamine, yeast extract and sodium butyrate in amounts sufficient to increase soluble rHuPH20 synthesis and increase cell cycle arrest, and

lowering the temperature compared to the temperature in step c) to a temperature sufficient to increase cell cycle arrest, increase cell viability and stabilize the soluble hyaluronidase; wherein:

the amount of L -alanyl- L -glutamine decreased compared to the amount of L -alanyl- L -glutamine in step c);

the amounts of yeast extract, glucose and sodium butyrate are increased compared to the amounts of yeast extract, glucose and sodium butyrate in step c); and

the feed medium is added to the culture at a volume of 0.5% or about 0.5% to 20% of the cell culture volume;

e) feeding the cells with a fourth feed medium containing glucose, L -alanyl- L -glutamine, yeast extract and sodium butyrate in amounts sufficient to increase soluble rHuPH20 synthesis and increase cell cycle arrest, and

lowering the temperature compared to the temperature in step d) to a temperature sufficient to increase cell cycle arrest, increase cell viability and stabilize the soluble hyaluronidase; wherein:

the amount of L -alanyl- L -glutamine and glucose is decreased compared to the amount of L -alanyl- L -glutamine and glucose in step d);

the amount of sodium butyrate is decreased compared to the amount of sodium butyrate in step d); and

the feed medium is added to the culture at a volume of 0.5% or about 0.5% to 20% of the cell culture volume;

f) continuing to culture the cells until viability drops below at least or about 50%;

g) obtaining the harvest cell culture fluid; and

h) purifying the rHuPH20 from the harvest cell culture fluid.

2. The method of claim 1 , wherein the temperature in step a) is or is about 37° C.

3. The method of claim 1 , wherein the temperature in step c) is or is about 36.5° C.

4. The method of claim 1 , wherein the temperature in step d) is 36° C.

5. The method of claim 1 , wherein the temperature in step e) is 35.5° C.

6. The method of claim 1 , wherein the harvest cell culture fluid is filtered prior to purification.

7. The method of claim 1 , wherein the soluble rHuPH20 purification is effected by column chromatography.

8. The method of claim 7 , wherein the column chromatography comprises beaded crosslinked agarose column chromatography, beaded crosslinked phenyl-substituted agarose column chromatography, amino phenyl boronate column chromatography and hydroxyapatite column chromatography.

9. The method of claim 1 , wherein the feed medium is added to the culture at a volume of 4% or about 4% of the cell culture volume.

10. A method for producing soluble rHuPH20, comprising:

a) inoculating cell medium in a bioreactor with an inoculum of cells that encode soluble rHuPH20 to produce a cell culture, wherein:

the cells comprise between 150 and 300 copies of nucleic acid encoding soluble rHuPH20;

the bioreactor contains at least 100 liters of cell culture;

the inoculation cell density is at or about 4×10 5 cells/mL; and

the cells are cultured at or at about 37° C.;

b) feeding the cells with a first feed medium containing or containing about 33 g/L glucose, 32 mM L -alanyl- L -glutamine, 16.6 g/L yeast extract and 33 mg/L insulin, wherein the feed medium is added to the culture at a volume of 4% or about 4% of the cell culture volume;

c) feeding the cells with a second feed medium containing or containing about 33 g/L glucose, 16 mM L-alanyl-L-glutamine, 33.4 g/L yeast extract and 0.92 g/L sodium butyrate, wherein the feed medium is added to the culture at a volume of 4% or about 4% of the cell culture volume; and

the temperature is lowered to 36.5° C.;

d) feeding the cells with a third feed medium containing or containing about 50 g/L glucose, 10 mM L-alanyl-L-glutamine, 50 g/L yeast extract and 1.8 g/L sodium butyrate, wherein the feed medium is added to the culture at a volume of 4% or about 4% of the cell culture volume; and

the temperature is lowered to 36° C.;

e) feeding the cells with a fourth feed medium containing or containing about 33 g/L glucose, 6.6 mM L-alanyl-L-glutamine, 50 g/L yeast extract and 0.92 g/L sodium butyrate, wherein the feed medium is added to the culture at a volume of 4% or about 4% of the cell culture volume; and

the temperature is lowered to 36° C.;

f) continuing to culture the cells until viability drops below at least or about 50%;

g) obtaining the harvest cell culture fluid;

h) filtering the harvest cell culture fluid;

i) purifying the rHuPH20 from the harvest culture fluid using beaded crosslinked agarose column chromatography, beaded crosslinked phenyl-substituted agarose column chromatography, amino phenyl boronate column chromatography and hydroxyapatite column chromatography.

11. A method for producing soluble rHuPH20, comprising:

a) inoculating cell medium in a bioreactor with an inoculum of cells that encode soluble rHuPH20 to produce a cell culture, wherein:

the cells comprise between 150 and 300 copies of nucleic acid encoding soluble rHuPH20;

the bioreactor contains at least 100 liters of cell culture;

the inoculation cell density is at or about 4×10 5 cells/mL; and

the cells are cultured at or about 37° C.;

b) feeding the cells with a first feed medium containing or containing about 33 g/L glucose, 32 mM L-alanyl-L-glutamine, 83.3 g/L yeast extract and 33 mg/L insulin, wherein the feed medium is added to the culture at a volume of 4% or about 4% of the cell culture volume;

c) feeding the cells with a second feed medium containing or containing about 33 g/L glucose, 13 mM L-alanyl-L-glutamine, 166.7 g/L yeast extract and 0.92 g/L sodium butyrate, wherein the feed medium is added to the culture at a volume of at or about 4% of the cell culture volume; and

the temperature is lowered to 36.5° C.;

d) feeding the cells with a third feed medium containing or containing about 50 g/L glucose, 10 mM L-alanyl-L-glutamine; 250 g/L yeast extract and 1.8 g/L sodium butyrate, wherein the feed medium is added to the culture at a volume of 4% or about 4% of the cell culture volume; and

the temperature is lowered to 36° C.;

e) feeding the cells with a fourth feed medium containing or containing about 33 g/L glucose, 6.7 mM L-alanyl-L-glutamine, 250 g/L yeast extract and 0.92 g/L sodium butyrate, wherein the feed medium is added to the culture at a volume of 4% or about 4% of the cell culture volume; and

the temperature is lowered to 36° C.;

f) continuing to culture the cells until viability drops below at least or about 50%;

g) obtaining the harvest cell culture fluid;

h) filtering the harvest cell culture fluid; and

i) purifying the rHuPH20 from the harvest culture fluid using beaded crosslinked agarose column chromatography, beaded crosslinked phenyl-substituted agarose column chromatography, amino phenyl boronate column chromatography and hydroxyapatite column chromatography.

12. The method of claim 1 , wherein at least or about 0.5, 1, 5, 10, 15, 20, 25, 30, 35 or 40 grams of soluble rHuPH20 is produced per 100 L of cell culture.

13. The method of claim 1 , wherein the specific activity of the soluble rHuPH20 is at least or about 80000, 100000, 120000, 140000, 160000 or 180,000 units/mg.

14. The method of claim 1 , wherein the volume of cell culture in the bioreactor is or is about 200, 300, 400, 500, 1000, 1500, 2000, 2500, 3000 or 3500 liters.

15. The method of claim 1 , wherein the cells that encode soluble rHuPH20 are DG44 CHO cells.

16. The method of claim 1 , wherein the rHuPH20 is encoded by nucleic acid set forth in SEQ ID NO:47.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2010
From: BAKER, DAVID; BOOKBINDER, LOUIS
To: HALOZYME THERAPEUTICS, INC.
Reel/Frame 024969/0965 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2010
From: HALOZYME THERAPEUTICS, INC.
To: HALOZYME, INC.
Reel/Frame 024969/0996 →
Continuity (2)
Provisional Application 61068622 · Mar 6, 2008
Related Publication 20110053247A1 · Mar 3, 2011